{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T16:30:10Z","timestamp":1703089810830},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12022-015-9358-7","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T08:34:51Z","timestamp":1423730091000},"page":"104-110","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunohistochemical Expression of p16 and p21 in Pituitary Tissue Adjacent to Pituitary Adenoma versus Pituitary Tissue Obtained at Autopsy: Is There a Difference?"],"prefix":"10.1007","volume":"26","author":[{"given":"Emilija","family":"Manojlovic Gacic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Skender-Gazibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Soldatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusko","family":"Dundjerovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Novica","family":"Boricic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savo","family":"Raicevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"9358_CR1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20401","volume":"112","author":"S Melmed","year":"2003","unstructured":"Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603\u201318.","journal-title":"J Clin Invest"},{"key":"9358_CR2","doi-asserted-by":"crossref","first-page":"10564","DOI":"10.1158\/0008-5472.CAN-07-0974","volume":"67","author":"V Chesnokova","year":"2007","unstructured":"Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, et al. (2007) Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer research 67:10564\u201372","journal-title":"Cancer research"},{"key":"9358_CR3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS el-Deiry","year":"1993","unstructured":"el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817\u201325","journal-title":"Cell"},{"key":"9358_CR4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/CCO.0b013e32835b639e","volume":"25","author":"NA Warfel","year":"2013","unstructured":"Warfel NA, El-Deiry WS (2013) p21WAF1 and tumourigenesis: 20 years after. Current opinion in oncology 25:52\u20138","journal-title":"Current opinion in oncology"},{"key":"9358_CR5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1134\/S000629791206003X","volume":"77","author":"VS Romanov","year":"2012","unstructured":"Romanov VS, Pospelov VA, Pospelova TV (2012) Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Mosc) 77:575\u201384","journal-title":"Biochemistry (Mosc)"},{"key":"9358_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1780","volume":"6","author":"BD Rowland","year":"2006","unstructured":"Rowland BD, Peeper DS (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6:11\u201323","journal-title":"Nat Rev Cancer"},{"key":"9358_CR7","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1002\/jcb.23296","volume":"112","author":"J Cmielova","year":"2011","unstructured":"Cmielova J, Rezacova M (2011) p21Cip1\/Waf1 protein and its function based on a subcellular localization [corrected]. Journal of cellular biochemistry 112:3502\u20136","journal-title":"Journal of cellular biochemistry"},{"key":"9358_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrrev.2010.01.009","volume":"704","author":"O Cazzalini","year":"2010","unstructured":"Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E (2010) Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res 704:12\u201320","journal-title":"Mutat Res"},{"key":"9358_CR9","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.0804810105","volume":"105","author":"V Chesnokova","year":"2008","unstructured":"Chesnokova V, Zonis S, Kovacs K, Ben-Shlomo A, Wawrowsky K, Bannykh S, et al. (2008) p21(Cip1) restrains pituitary tumor growth. Proceedings of the National Academy of Sciences of the United States of America 105:17498\u2013503","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9358_CR10","unstructured":"Human Protein Atlas (2014) CDKN1A. http:\/\/www.proteinatlas.org\/ENSG00000124762\/antibody Accessed 3 November 2014"},{"key":"9358_CR11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4. Nature 366:704\u20137.","journal-title":"Nature"},{"key":"9358_CR12","unstructured":"Human Protein Atlas (2014) CDKN2A http:\/\/www.proteinatlas.org\/ENSG00000147889\/antibody Accessed 3 November 2014."},{"key":"9358_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14310\/horm.2002.1358","volume":"11","author":"KI Alexandraki","year":"2012","unstructured":"Alexandraki KI, Munayem Khan M, Chahal HS, Dalantaeva NS, Trivellin G, Berney DM, et al. (2012) Oncogene-induced senescence in pituitary adenomas and carcinomas. Hormones (Athens, Greece) 11:297\u2013307","journal-title":"Hormones (Athens, Greece)"},{"key":"9358_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1677\/erc.0.0100323","volume":"10","author":"WE Farrell","year":"2003","unstructured":"Farrell WE, Clayton RN (2003) Epigenetic change in pituitary tumorigenesis. Endocr Relat Cancer 10:323\u201330","journal-title":"Endocr Relat Cancer"},{"key":"9358_CR15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","volume":"130","author":"H Rayess","year":"2012","unstructured":"Rayess H, Wang MB, Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. International journal of cancer Journal international du cancer 130:1715\u201325","journal-title":"International journal of cancer Journal international du cancer"},{"key":"9358_CR16","doi-asserted-by":"crossref","first-page":"9381","DOI":"10.1158\/0008-5472.CAN-10-0801","volume":"70","author":"S Takeuchi","year":"2010","unstructured":"Takeuchi S, Takahashi A, Motoi N, Yoshimoto S, Tajima T, Yamakoshi K, et al. (2010) Intrinsic cooperation between p16INK4a and p21Waf1\/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer research 70:9381\u201390","journal-title":"Cancer research"},{"key":"9358_CR17","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/jcem.87.6.8517","volume":"87","author":"M Korbonits","year":"2002","unstructured":"Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, et al. (2002) Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 87:2635\u201343","journal-title":"J Clin Endocrinol Metab"},{"key":"9358_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11060-013-1349-2","volume":"116","author":"Y Xu","year":"2014","unstructured":"Xu Y, Wang Y, Ma G, Wang Q, Wei G (2014) CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation. J Neurooncol 116:625\u201332","journal-title":"J Neurooncol"},{"key":"9358_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jocn.2013.04.034","volume":"21","author":"W Li","year":"2014","unstructured":"Li W, Zhang Y, Zhang M, Huang G, Zhang Q (2014) Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion. J Clin Neurosci 21:137\u201341","journal-title":"J Clin Neurosci"},{"key":"9358_CR20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.wneu.2013.09.035","volume":"81","author":"EH Lee","year":"2014","unstructured":"Lee EH, Kim KH, Kwon JH, Kim HD, Kim YZ (2014) Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma. World Neurosurg 81:563\u201375","journal-title":"World Neurosurg"},{"key":"9358_CR21","doi-asserted-by":"crossref","first-page":"e62424","DOI":"10.1371\/journal.pone.0062424","volume":"8","author":"LM Colli","year":"2013","unstructured":"Colli LM, Saggioro F, Serafini LN, Camargo RC, Machado HR, Moreira AC, et al. (2013) Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors. PLoS One 8:e62424","journal-title":"PLoS One"},{"key":"9358_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11102-012-0436-2","volume":"16","author":"H Akinci","year":"2013","unstructured":"Akinci H, Kapucu A, Dar KA, Celik O, Tutunculer B, Sirin G, et al. (2013) Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior. Pituitary 16:386\u201392","journal-title":"Pituitary"},{"key":"9358_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jocn.2011.07.029","volume":"19","author":"Z Miao","year":"2012","unstructured":"Miao Z, Miao Y, Lin Y, Lu X (2012) Overexpression of the Notch3 receptor in non-functioning pituitary tumours. J Clin Neurosci 19:107\u201310","journal-title":"J Clin Neurosci"},{"key":"9358_CR24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1227\/NEU.0b013e3182417e76","volume":"70","author":"X Liu","year":"2012","unstructured":"Liu X, Ma S, Yao Y, Li G, Feng M, Deng K, et al. (2012) Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor behavior. Neurosurgery 70:1274\u201380","journal-title":"Neurosurgery"},{"key":"9358_CR25","doi-asserted-by":"crossref","first-page":"E1918","DOI":"10.1210\/jc.2013-2602","volume":"98","author":"EA Garcia","year":"2013","unstructured":"Garcia EA, Trivellin G, Aflorei ED, Powell M, Grieve J, Alusi G, et al. (2013) Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly? J Clin Endocrinol Metab 98:E1918-26","journal-title":"J Clin Endocrinol Metab"},{"key":"9358_CR26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1309\/AJCP37TLZLTUAOJL","volume":"141","author":"DA Mordes","year":"2014","unstructured":"Mordes DA, Lynch K, Campbell S, Dias-Santagata D, Nose V, Louis DN, et al. (2014) VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations. Am J Clin Pathol 141:811\u20135","journal-title":"Am J Clin Pathol"},{"key":"9358_CR27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature medicine 4:844\u20137","journal-title":"Nature medicine"},{"key":"9358_CR28","volume-title":"Pathology and genetics of tumours of endocrine organs","author":"RA DeLellis","year":"2004","unstructured":"DeLellis RA (2004) Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press"},{"key":"9358_CR29","doi-asserted-by":"crossref","first-page":"e53313","DOI":"10.1371\/journal.pone.0053313","volume":"8","author":"M Sawicka","year":"2013","unstructured":"Sawicka M, Pawlikowski J, Wilson S, Ferdinando D, Wu H, Adams PD, et al. (2013) The specificity and patterns of staining in human cells and tissues of p16INK4a antibodies demonstrate variant antigen binding. PLoS One 8:e53313","journal-title":"PLoS One"},{"key":"9358_CR30","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE (1987). Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138\u201340","journal-title":"Pathologe"},{"key":"9358_CR31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593\u2013602","journal-title":"Cell"},{"key":"9358_CR32","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1038\/sj.onc.1210578","volume":"26","author":"V Quereda","year":"2007","unstructured":"Quereda V, Martinalbo J, Dubus P, Carnero A, Malumbres M (2007) Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression. Oncogene 26:7665\u201374","journal-title":"Oncogene"},{"key":"9358_CR33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2174\/138945012803529983","volume":"13","author":"K Tominaga","year":"2012","unstructured":"Tominaga K, Pereira-Smith OM (2012) The role of chromatin reorganization in the process of cellular senescence. Current drug targets 13:1593\u2013602","journal-title":"Current drug targets"},{"key":"9358_CR34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mad.2005.09.002","volume":"127","author":"U Herbig","year":"2006","unstructured":"Herbig U, Sedivy JM (2006) Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 127:16\u201324","journal-title":"Mech Ageing Dev"},{"key":"9358_CR35","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00535-013-0900-4","volume":"49","author":"Y Huang","year":"2013","unstructured":"Huang Y, Wang W, Chen Y, Huang Y, Zhang J, He S, et al. (2013) The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients. J Gastroenterol 49:1441\u201352","journal-title":"J Gastroenterol"},{"key":"9358_CR36","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1101\/gad.1676108","volume":"22","author":"T Abbas","year":"2008","unstructured":"Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A (2008) PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 22:2496\u2013506","journal-title":"Genes Dev"},{"key":"9358_CR37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.molcel.2007.06.013","volume":"27","author":"V Amador","year":"2007","unstructured":"Amador V, Ge S, Santamaria PG, Guardavaccaro D, Pagano M (2007) APC\/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell 27:462\u201373","journal-title":"Mol Cell"},{"key":"9358_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0092-8674(03)00755-4","volume":"115","author":"J Bloom","year":"2003","unstructured":"Bloom J, Amador V, Bartolini F, DeMartino G, Pagano M (2003) Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 115:71\u201382","journal-title":"Cell"},{"key":"9358_CR39","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.M301774200","volume":"278","author":"G Bornstein","year":"2003","unstructured":"Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M, Hershko A (2003) Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 278:25752\u20137","journal-title":"J Biol Chem"},{"key":"9358_CR40","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1101\/gad.1703708","volume":"22","author":"Y Kim","year":"2008","unstructured":"Kim Y, Starostina NG, Kipreos ET (2008) The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev 22:2507\u201319","journal-title":"Genes Dev"},{"key":"9358_CR41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1101\/gad.11.7.847","volume":"11","author":"J LaBaer","year":"1997","unstructured":"LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, et al. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847\u201362","journal-title":"Genes Dev"},{"key":"9358_CR42","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/MCB.25.8.3364-3387.2005","volume":"25","author":"BC Dash","year":"2005","unstructured":"Dash BC, El-Deiry WS (2005) Phosphorylation of p21 in G2\/M promotes cyclin B-Cdc2 kinase activity. Mol Cell Biol 25:3364\u201387","journal-title":"Mol Cell Biol"},{"key":"9358_CR43","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.4161\/cc.9.12.11988","volume":"9","author":"Z Lu","year":"2010","unstructured":"Lu Z, Hunter T (2010) Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors. Cell cycle (Georgetown, Tex) 9:2342\u201352","journal-title":"Cell cycle (Georgetown, Tex)"},{"key":"9358_CR44","doi-asserted-by":"crossref","first-page":"e38085","DOI":"10.1371\/journal.pone.0038085","volume":"7","author":"ST Yong","year":"2012","unstructured":"Yong ST, Wang XF (2012) A novel, non-apoptotic role for Scythe\/BAT3: a functional switch between the pro- and anti-proliferative roles of p21 during the cell cycle. PLoS One 7:e38085","journal-title":"PLoS One"},{"key":"9358_CR45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/path.833","volume":"193","author":"N Seemann","year":"2001","unstructured":"Seemann N, Kuhn D, Wrocklage C, Keyvani K, Hackl W, Buchfelder M, et al. (2001) CDKN2A\/p16 inactivation is related to pituitary adenoma type and size. The Journal of pathology 193:491\u20137","journal-title":"The Journal of pathology"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-015-9358-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-015-9358-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-015-9358-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:01:07Z","timestamp":1559440867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-015-9358-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["9358"],"URL":"https:\/\/doi.org\/10.1007\/s12022-015-9358-7","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]}}}